Pediatric Coccidioidomycosis: Case Series From a California Pediatric Infectious Diseases Clinic.
Lee, Lauren A. MD, MPH *; Sondermeyer Cooksey, Gail L. MPH *; Kim, Janice J. MD, MPH *; Kahal, Amandeep MD +; Gilliss, Debra MD, MPH *; Naeem, Fouzia MD, MS +; McCarty, James M. MD ++; Vugia, Duc J. MD, MPH *
Pediatric Infectious Disease Journal.
38(2):115-121, February 2019.
(Format: HTML, PDF)
Background: Coccidioidomycosis is not as well described in the pediatric population as it is in the adult population. We describe clinical findings, diagnosis and management of coccidioidomycosis in 108 pediatric patients seen in an outpatient clinic in the California Central Valley, an area endemic for coccidioidomycosis.
Methods: We reviewed medical records of a convenience sample of pediatric patients (<=17 years of age) diagnosed with coccidioidomycosis who visited an infectious diseases clinic in Madera, CA, during January 1 to October 1, 2012. We described demographic characteristics, symptoms, diagnostic testing, extent of infection (acute/pulmonary or disseminated), treatment and management.
Results: Of 108 patients, 90 (83%) had acute/pulmonary coccidioidomycosis and 18 (17%) had disseminated disease. The median age at diagnosis was 9 years (range, 5 months to 17 years). Only 3 (3%) patients were immunocompromised. Before coccidioidomycosis diagnosis, 72 (82%) patients received antibiotics, and 31 (29%) had at least 1 negative coccidioidomycosis serology at the time of or before diagnosis. Coccidioidomycosis was diagnosed significantly later after symptom onset among patients with disseminated (median, 57 days) than with acute/pulmonary (median, 16 days) disease (p < 0.01). A total of 104 (96%) patients received antifungal therapy, 51 (47%) visited an emergency room and 59 (55%) were hospitalized with a median stay of 44 days (range, 1-272 days).
Conclusions: Substantial acute/pulmonary and disseminated coccidioidomycosis was seen among pediatric patients at this infectious disease clinic in California. In endemic areas, increased coccidioidomycosis awareness and vigilance among families and providers is necessary to facilitate early diagnosis and appropriate management.
Copyright (C) 2019 Wolters Kluwer Health, Inc. All rights reserved.